{"name":"Allodynic Therapeutics, Inc","slug":"allodynic-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Acetaminophen Alone","genericName":"Acetaminophen Alone","slug":"acetaminophen-alone","indication":"Pain relief","status":"phase_2"}]}],"pipeline":[{"name":"Acetaminophen Alone","genericName":"Acetaminophen Alone","slug":"acetaminophen-alone","phase":"phase_2","mechanism":"Inhibits cyclooxygenase enzymes","indications":["Pain relief","Fever reduction"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxNWE13UWg0d1UtcXpDY1BhTEwtNFUzU0pxWC1PcDgySUsxblBXai1aSkdrNmphaUtEQVRrVi04VzBGMUwwaG9YYVFiUGpoR0JFWTNaYldhWENyX3ZWRHJDSC1jdU5uM2FfN2Y3YkpHTVQ5VzVub2I1QUI3X3Frd3k3MndoU3k4eFIyNG5hT2JGNElYV1pMRzFyeU1kZmlhYlp0RG1IYmlIQkdmQmY4bjZ4UHkzaklVVTVETVVuZHlhQXJlUGRPWFVGeFRSa1dDVHdiOXV3cWJVenlUQWZpN3VFbk1RVXZPbFRzelNVZg?oc=5","date":"2026-04-02","type":"pipeline","source":"Barchart.com","summary":"Chronic and Acute Pain Treatment Pipeline Shows Strong Momentum as 180+ Pharma Companies in the Race | DelveInsight - Barchart.com","headline":"Chronic and Acute Pain Treatment Pipeline Shows Strong Momentum as 180+ Pharma Companies in the Race | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAJBVV95cUxPbTQ4dFNtN3ZWMHZHY1NwMmgzbVZvVzF0VElQNWVWWXVHQ1BjTXIxTmQ4VWY4RGdfVlFVYkU0LVBPbHZJQThMQmRHRGFYc19yYXZOeFJVSjh2UFNoR2hfT0tHZmZYdmdpVDJlOWtnQklZSERqdWxidWtvVjJCLWQyMVladEh4b0hsZ0lXZGRkWXFsc1FLU1hjWkdDdmx3WmNSQ0FfT1FGcmIxejI3Rnk3LWpCbm8yNS0xQmUtVFRsajhtTHdrWkZ6S3gwNTNxd1cxTkE3RWZnS2t6V3FLY2FUN2JQbGRrVWlMY1kzRkdRcUVVMms3WUhPQnhCbkwzeWxsRnFva0oyVEVjdUx6ZTAycFBQakh0dXVSRENRb2hfTjBoNEtUOTZGdGtNem5nemJBaEQ0elRhT245eG9H?oc=5","date":"2026-01-28","type":"trial","source":"GlobeNewswire","summary":"Chronic and Acute Pain Clinical Trial Pipeline Analysis: - GlobeNewswire","headline":"Chronic and Acute Pain Clinical Trial Pipeline Analysis:","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogJBVV95cUxOUmQybk9TX2VZZTFLQVZuek1GNl9ZdUU2eFlSZTdVTWpqZEtLU3M2MnRVLURYT0VfWVFBMk95YTZEOHF0ZHhDZmFIcU0yWHBQUWY3TTQybWFVWmUyMkNBdlNGZ3l0TzhOSUJwZklSd0VONXFLd3RTSER4dDV5T1lkeUNrYnM4NTZzb1ZzVUFualNPV25vSXRIaXU4U2l4YjVkQUlQeE5MeWtpd3FqaHk4TVJwVWYyRS0yb0piNU9vZ2ZFUG1zdTJCWEdYbG1nQW1PNW9CWF9fWkEyY1Nwek9IenlzcERnTk96SzNxOWdvSDVGeUFXOXdZRFRrcndESU01SkNPMVN3X1pmQnQ5V1A1WllCaUhrRzJLSHVTdTY0cF80QQ?oc=5","date":"2025-09-24","type":"trial","source":"PR Newswire","summary":"Moderate-to-Severe Acute Pain Market Anticipates Impressive Growth Trajectory at a CAGR of 14% During the Study Period (2020-2034) | DelveInsight - PR Newswire","headline":"Moderate-to-Severe Acute Pain Market Anticipates Impressive Growth Trajectory at a CAGR of 14% During the Study Period (","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAJBVV95cUxPOFpISUVmRloyZnR4c0dVT25yNVUxS2Frc3U3WHc2d3pxUzEtdmtxRDZWb1gyUUphc1pCSERPMHA3TnkyZlBuRmdHWGNScDJ4OFFDaW1rMHQzWjZFSksxZlQ3YjM0QVl2aHA5ZWJBNjdYdHNrZVZMUWxCSlpZYkJBV1JTZ01lMHZvVXQ2dVYtSnZUZ1hJTWtLSzlMOFlBTEJtTGRoTVRZNFRtTG5QckVzbFVKZG1WTXY1NHRuMXNxc09jV0FfRFV6M1llaDVWSEtWSzVvQzNrSXBMQmZHODBkZ1ZYSEtwVHBhQWkxZVJKVmhVTHNWNm5mYUlMdWNqZHNxaFdaUmhJWG82bUI3elM1NjhmZmJ1S2VX?oc=5","date":"2025-06-16","type":"pipeline","source":"PR Newswire","summary":"Chronic Lower Back Pain Market to Expand Significantly During the Forecast Period (2025-2034) with Game-Changing Therapies | DelveInsight - PR Newswire","headline":"Chronic Lower Back Pain Market to Expand Significantly During the Forecast Period (2025-2034) with Game-Changing Therapi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogJBVV95cUxOdEprVnFpcVpYMDkwQUVhS2ZLbXV4MUtvWm1UU0ViN3pGbVZKN1ZoWmJaV1FXcjZEb0VQTjJmYTl0Q20yTmR4LVh0UktJYkZyc2pnMHl3dHBnNXlkcmdjX3pvSHJfSk1WTGNZOUJBS2t3aEdraF9wQW5Ta3BFeTM5TTJ3OU9lRUt5NVFrQ0RqbmxWVGFoNlRXUlFCZWtVZDJrX0pxbU1yUm5PM3E3WHJvbV9SamUzaVgtaXhHRHpMSmdOUUhzSE1KMElNTzhINUhleFlqUVl3N3h2V1hGY3ZMc2h1akZpQXo5aktWdWZtSzVBMFFzQU11M2g3ZFFwczV0aWVJeWJfVC02dDdvODVTWkVXUDdEeUprdE9BdWV6ZzNwdw?oc=5","date":"2025-05-21","type":"regulatory","source":"PR Newswire","summary":"Migraine Market Enters New Era Following Satsuma Pharmaceuticals' ATZUMI and Amneal Pharmaceuticals' BREKIYA Regulatory Approval | DelveInsight - PR Newswire","headline":"Migraine Market Enters New Era Following Satsuma Pharmaceuticals' ATZUMI and Amneal Pharmaceuticals' BREKIYA Regulatory ","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMivgJBVV95cUxQODRSeHZ1WTg0bnVlRGJqRlNEbDQzZGZ6ejQxNGI0amtJR19NQ1dEeFY5Y2x2MkxpU0pMY1VHSlFkNnRpZy02OGcybmNJdW9YcXJJRmcwUnFQMUNhUDNmTWlMbjdoeFdMVTJTVXUtbjUyeERyWHRqT3dJQkx0TklXRjVzUFNQZHU1WFIyNDdpekFXenprZFc3Z3VXM3FhazBVX202Ukk4S01xMTBGem5ZNE9Xc3V0ZHV4MVpDYk4zVWVSTjNfZnVBN0NyWFZNUk13QVF6ckFObUJhajh4QVNsbjJWWGZieVhxQU9LN3VaWFJCcXZMakZUZDU5MjZsQkJmX0FSWWtxNU5JbXdZWTF0Wnc4SlA3SzJweU9LcHBXYXlCTndxTVliSlh0LU9ta3Qtb1ItV2xrZVVta0k2MWc?oc=5","date":"2025-01-30","type":"trial","source":"GlobeNewswire","summary":"Chronic Pain Clinical Trial Pipeline Experiences Momentum: - GlobeNewswire","headline":"Chronic Pain Clinical Trial Pipeline Experiences Momentum:","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}